Frontline (FRO) had the highest return in December 2014 by a US stock with a market cap of $500M+, returning 83.2%.
| ASSET | MONTH | % RETURN |
|---|---|---|
Frontline (FRO) | December 2014 | 83.21% |
Cytokinetics (CYTK) | December 2014 | 72.26% |
Stewards Inc Common Stock (SWRD) | December 2014 | 57.89% |
Xenon Pharmaceuticals (XENE) | December 2014 | 51.34% |
Veracyte (VCYT) | December 2014 | 48.62% |
Iradimed (IRMD) | December 2014 | 46.59% |
Xencor (XNCR) | December 2014 | 42.45% |
Ocular Therapeutix (OCUL) | December 2014 | 40% |
Varonis Systems (VRNS) | December 2014 | 38.93% |
eXp World (AGNT) | December 2014 | 37.24% |
Clear Channel Outdoor (CCO) | December 2014 | 36.82% |
Ingles Markets (IMKTA) | December 2014 | 36.66% |
CorMedix (CRMD) | December 2014 | 36.43% |
Enphase Energy (ENPH) | December 2014 | 36.1% |
Chefs Warehouse (CHEF) | December 2014 | 35.13% |
QuinStreet (QNST) | December 2014 | 33.41% |
Nutex Health (NUTX) | December 2014 | 33.33% |
Iovance Biotherapeutics (IOVA) | December 2014 | 31.17% |
Digi International (DGII) | December 2014 | 29.93% |
QXO (QXO) | December 2014 | 29.41% |
Cirrus Logic (CRUS) | December 2014 | 29.15% |
Arrowhead Pharmaceuticals (ARWR) | December 2014 | 28.13% |
IAMGold (IAG) | December 2014 | 26.76% |
MACOM Technology Solutions (MTSI) | December 2014 | 25.88% |
Barrett Business Services (BBSI) | December 2014 | 25.81% |